children with ADHD aged 7 to 9.9 years were randomized to receive medication
management consisting of methylphenidate, intensive behavioral treatment,
a combination of both, or standard community care over 14 months.1
management began with methylphenidate TID dosing titrated to maximal
effect through monthly visits with pharmacotherapists.
treatment included parent training in both group and individual weekly
sessions tapered over time, child-focused treatment with an 8-week summer
program, and school-based intervention with bi-weekly teacher consultation
and paraprofessional aides working with the child.
family report of side effects in combined treatment and medication management
subjects, 35.9% reported none, 49.8% reported mild side effects, 11.4%
moderate, and 2.9% severe.